We are live on ! Find out more
Jane Street

Jane Street Portfolio holdings

AUM $777B
1-Year Est. Return 61.18%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+61.18%
3 Year Est. Return
+147.64%
5 Year Est. Return
+157.48%
10 Year Est. Return
+673.77%
AUM
$256B
AUM Growth
+$54.4B
Cap. Flow
+$36.7B
Cap. Flow %
14.37%
Top 10 Hldgs %
36.58%
Holding
10,953
New
1,924
Increased
4,219
Reduced
3,459
Closed
1,267

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 2.5%
2 Technology 2.1%
3 Healthcare 1.18%
4 Financials 0.9%
5 Industrials 0.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDF icon
9276
PUT
Cardiff Oncology
CRDF
$74.7M
$93K ﹤0.01%
+14,000
New +$119K
HITI
9277
High Tide
HITI
$201M
$93K ﹤0.01%
+11,668
New +$93.4K
TRVG
9278
trivago
TRVG
$388M
$93K ﹤0.01%
5,616
-16,525
-75% -$305K
GSV
9279
DELISTED
Gold Standard Ventures Corp.
GSV
$93K ﹤0.01%
166,046
+43,157
+35% +$25.4K
EVFM
9280
CALL
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$93K ﹤0.01%
+5,487
New +$104K
IVAN.WS
9281
DELISTED
Ivanhoe Capital Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A
IVAN.WS
$93K ﹤0.01%
50,617
-3,598
-7% -$5.14K
YAC.WS
9282
DELISTED
Yucaipa Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A
YAC.WS
$93K ﹤0.01%
69,581
-59
-0.1% -$65
HTT
9283
PUT
High Templar Tech Ltd
HTT
$385M
$92K ﹤0.01%
38,200
-1,749,000
-98% -$3.74M
RMTI icon
9284
Rockwell Medical
RMTI
$28.3M
$92K ﹤0.01%
921
+781
+558% +$80.6K
SPPI
9285
PUT
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$92K ﹤0.01%
+24,600
New +$85.5K
STPC.WS
9286
DELISTED
Star Peak Corp II Warrants, each whole warrant exercisable for one share of Class A common stock at
STPC.WS
$92K ﹤0.01%
51,696
+778
+2% +$1.27K
EEX
9287
DELISTED
Emerald Holding
EEX
$91K ﹤0.01%
+16,923
New +$90.7K
XPOA.WS
9288
DELISTED
DPCM Capital, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at
XPOA.WS
$91K ﹤0.01%
70,744
+1,531
+2% +$1.88K
CBIO
9289
Crescent Biopharma
CBIO
$610M
$90K ﹤0.01%
386
+271
+236% +$69K
IRON icon
9290
CALL
Disc Medicine
IRON
$2.97B
$90K ﹤0.01%
+463
New +$152K
LVO icon
9291
LiveOne
LVO
$56.9M
$90K ﹤0.01%
1,913
-4,485
-70% -$195K
CSTA.WS
9292
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$90K ﹤0.01%
100,167
+167
+0.2% +$129
GSKY
9293
PUT
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
$90K ﹤0.01%
16,300
-4,600
-22% -$27.5K
CYXTW
9294
DELISTED
Cyxtera Technologies, Inc. Warrant
CYXTW
$90K ﹤0.01%
44,423
-2,075
-4% -$3.52K
CENHW
9295
DELISTED
Centricus Acquisition Corp. Warrant
CENHW
$90K ﹤0.01%
+64,380
New +$68.3K
ADMA icon
9296
ADMA Biologics
ADMA
$2.25B
$89K ﹤0.01%
55,477
+32,865
+145% +$57.8K
ANY icon
9297
Sphere 3D
ANY
$17.1M
$89K ﹤0.01%
+486
New +$69.1K
IBIO icon
9298
iBio
IBIO
$69.1M
$89K ﹤0.01%
118
+22
+23% +$16K
KALA icon
9299
KALA BIO
KALA
$14.2M
$88K ﹤0.01%
7
-15
-68% -$236K
SMSI icon
9300
CALL
Smith Micro Software
SMSI
$15.7M
$88K ﹤0.01%
423
+105
+33% +$22.5K

Similar funds

Jane Street's Q2 2021 Portfolio in Review

As of Q2 2021, Jane Street held 10,953 positions worth $256B, up 27% from $201B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Jane Street deployed $36.7B of net new capital in Q2 2021, opening 1,924 new positions and adding to 4,219 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 2.5% of assets, down from 2.8% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Baidu, an estimated $964M trimmed.

  • Jane Street's largest Q2 2021 buy was iShares MSCI EAFE ETF: 6,071,963 shares worth $479M.
  • Jane Street added most to iShares MBS ETF in Q2 2021, an estimated $629M increase.
  • Jane Street's biggest Q2 2021 reduction was Baidu, cutting an estimated $964M.
  • Jane Street fully exited Invesco Senior Loan ETF in Q2 2021, selling an estimated $369M.
  • Jane Street's ten largest holdings make up 37% of its $256B portfolio in Q2 2021.
  • Jane Street opened 1,924 new positions and closed 1,267 in Q2 2021.
  • Jane Street's portfolio value rose 27% quarter-over-quarter to $256B.

Based on Jane Street's 13F filing for Q2 2021, filed 16 Aug 2021.